Dynamic and combinatorial control of gene expression by nuclear retinoic acid receptors (RARs)
暂无分享,去创建一个
[1] H. Gronemeyer,et al. Differential action on coregulator interaction defines inverse retinoid agonists and neutral antagonists. , 2009, Chemistry & biology.
[2] I. Raška,et al. SUG-1 Plays Proteolytic and Non-proteolytic Roles in the Control of Retinoic Acid Target Genes via Its Interaction with SRC-3* , 2009, Journal of Biological Chemistry.
[3] I. Raška,et al. Inhibition of the peptidyl-prolyl-isomerase Pin1 enhances the responses of acute myeloid leukemia cells to retinoic acid via stabilization of RARalpha and PML-RARalpha. , 2009, Cancer research.
[4] C. Ferry,et al. A coordinated phosphorylation cascade initiated by p38MAPK/MSK1 directs RARα to target promoters , 2009, The EMBO journal.
[5] Lu Chen,et al. Retinoic acid-gated sequence-specific translational control by RARα , 2008, Proceedings of the National Academy of Sciences.
[6] Lu Chen,et al. Synaptic Signaling by All-Trans Retinoic Acid in Homeostatic Synaptic Plasticity , 2008, Neuron.
[7] Lu Chen,et al. Retinoic acid regulates RARα-mediated control of translation in dendritic RNA granules during homeostatic synaptic plasticity , 2008, Proceedings of the National Academy of Sciences.
[8] Danny Reinberg,et al. Is there a code embedded in proteins that is based on post-translational modifications? , 2008, Nature Reviews Molecular Cell Biology.
[9] Li-Na Wei,et al. Modulation of retinoic acid receptor alpha activity by lysine methylation in the DNA binding domain. , 2008, Journal of proteome research.
[10] Pawan Gupta,et al. Retinoic acid-stimulated sequential phosphorylation, PML recruitment, and SUMOylation of nuclear receptor TR2 to suppress Oct4 expression , 2008, Proceedings of the National Academy of Sciences.
[11] M. Cammarota,et al. Retinoic acid induces apoptosis by a non-classical mechanism of ERK1/2 activation. , 2008, Toxicology in vitro : an international journal published in association with BIBRA.
[12] J. L. Napoli,et al. The Nuclear Transcription Factor RARα Associates with Neuronal RNA Granules and Suppresses Translation* , 2008, Journal of Biological Chemistry.
[13] T. Schug,et al. Overcoming retinoic acid-resistance of mammary carcinomas by diverting retinoic acid from PPARβ/δ to RAR , 2008, Proceedings of the National Academy of Sciences.
[14] C. Glass,et al. TBL1 and TBLR1 phosphorylation on regulated gene promoters overcomes dual CtBP and NCoR/SMRT transcriptional repression checkpoints. , 2008, Molecular cell.
[15] B. O’Malley,et al. Atypical protein kinase C regulates dual pathways for degradation of the oncogenic coactivator SRC-3/AIB1. , 2008, Molecular cell.
[16] F. Wang,et al. Acinus-S′ Represses Retinoic Acid Receptor (RAR)-Regulated Gene Expression through Interaction with the B Domains of RARs , 2008, Molecular and Cellular Biology.
[17] W. Miller,et al. Topoisomerase II (cid:2) Negatively Modulates Retinoic Acid Receptor (cid:3) Function: a Novel Mechanism of Retinoic Acid Resistance (cid:1) , 2022 .
[18] H. Stunnenberg,et al. A TFTC/STAGA module mediates histone H2A and H2B deubiquitination, coactivates nuclear receptors, and counteracts heterochromatin silencing. , 2008, Molecular cell.
[19] J. L. Napoli,et al. All‐trans‐retinoic acid stimulates translation and induces spine formation in hippocampal neurons through a membrane‐associated RARα , 2008 .
[20] J. L. Napoli,et al. All-trans-retinoic acid stimulates translation and induces spine formation in hippocampal neurons through a membrane-associated RARalpha. , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[21] Jessica Zucman-Rossi,et al. Loss of Trim24 (Tif1α) gene function confers oncogenic activity to retinoic acid receptor alpha , 2007, Nature Genetics.
[22] L. Gudas,et al. Retinoic Acid Receptor Isotype Specificity in F9 Teratocarcinoma Stem Cells Results from the Differential Recruitment of Coregulators to Retinoic Acid Response Elements* , 2007, Journal of Biological Chemistry.
[23] L. Altucci,et al. RAR and RXR modulation in cancer and metabolic disease , 2007, Nature Reviews Drug Discovery.
[24] Lucia Altucci,et al. Design of selective nuclear receptor modulators: RAR and RXR as a case study , 2007, Nature Reviews Drug Discovery.
[25] A. D. de Lera,et al. Rapid, nongenomic actions of retinoic acid on phosphatidylinositol-3-kinase signaling pathway mediated by the retinoic acid receptor. , 2007, Molecular endocrinology.
[26] J. De-Castro Arce,et al. Retinoic Acid Receptor β Silences Human Papillomavirus-18 Oncogene Expression by Induction of de Novo Methylation and Heterochromatinization of the Viral Control Region* , 2007, Journal of Biological Chemistry.
[27] L. Gudas,et al. Retinoid regulated association of transcriptional co-regulators and the polycomb group protein SUZ12 with the retinoic acid response elements of Hoxa1, RARbeta(2), and Cyp26A1 in F9 embryonal carcinoma cells. , 2007, Journal of molecular biology.
[28] B. O’Malley,et al. SRC-3 Coactivator Functional Lifetime Is Regulated by a Phospho-Dependent Ubiquitin Time Clock , 2007, Cell.
[29] C. Chomienne,et al. Epigenetic patterns of the retinoic acid receptor β2 promoter in retinoic acid-resistant thyroid cancer cells , 2007, Oncogene.
[30] S. Lalevée,et al. Protein kinases and the proteasome join in the combinatorial control of transcription by nuclear retinoic acid receptors. , 2007, Trends in cell biology.
[31] F. Sladek,et al. Phosphorylation of a conserved serine in the deoxyribonucleic acid binding domain of nuclear receptors alters intracellular localization. , 2007, Molecular endocrinology.
[32] S. Collins,et al. CaMKII regulates retinoic acid receptor transcriptional activity and the differentiation of myeloid leukemia cells. , 2007, The Journal of clinical investigation.
[33] S. Khan,et al. Lysine Trimethylation of Retinoic Acid Receptor-α , 2007, Molecular & Cellular Proteomics.
[34] Mu Wang,et al. CSK Controls Retinoic Acid Receptor (RAR) Signaling: a RAR-c-SRC Signaling Axis Is Required for Neuritogenic Differentiation , 2007, Molecular and Cellular Biology.
[35] L. Gudas,et al. Retinoic acid receptor isotype specificity in F9 teratocarcinoma stem cells results from the differential recruitment of coregulators to retinoic response elements. , 2007, The Journal of biological chemistry.
[36] R. Nasr,et al. Acute promyelocytic leukemia: new issues on pathogenesis and treatment response. , 2007, The international journal of biochemistry & cell biology.
[37] S. Khan,et al. Lysine trimethylation of retinoic acid receptor-alpha: a novel means to regulate receptor function. , 2007, Molecular & cellular proteomics : MCP.
[38] G. Eichele,et al. International Union of Pharmacology. LX. Retinoic Acid Receptors , 2006, Pharmacological Reviews.
[39] Gregor Eichele,et al. International Union of Pharmacology. LXIII. Retinoid X Receptors , 2006, Pharmacological Reviews.
[40] Vincent Laudet,et al. Overview of Nomenclature of Nuclear Receptors , 2006, Pharmacological Reviews.
[41] M. Beato,et al. Induction of progesterone target genes requires activation of Erk and Msk kinases and phosphorylation of histone H3. , 2006, Molecular cell.
[42] B. Haendler,et al. Post-translational modifications of steroid receptors. , 2006, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[43] V. Cavaillès,et al. The nuclear receptor transcriptional coregulator RIP140 , 2006, Nuclear receptor signaling.
[44] Hans Elmlund,et al. The cyclin-dependent kinase 8 module sterically blocks Mediator interactions with RNA polymerase II , 2006, Proceedings of the National Academy of Sciences.
[45] B. Lefebvre,et al. Down-regulation of the tumor suppressor gene retinoic acid receptor beta2 through the phosphoinositide 3-kinase/Akt signaling pathway. , 2006, Molecular endocrinology.
[46] Masaru Mitsushima,et al. Abl kinase interacts with and phosphorylates vinexin , 2006, FEBS letters.
[47] B. Lefebvre,et al. Distinct Roles of the Steroid Receptor Coactivator 1 and of MED1 in Retinoid-induced Transcription and Cellular Differentiation* , 2006, Journal of Biological Chemistry.
[48] D. Moras,et al. Phosphorylation by PKA potentiates retinoic acid receptor alpha activity by means of increasing interaction with and phosphorylation by cyclin H/cdk7. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[49] Christopher J. Oldfield,et al. Intrinsic disorder in transcription factors. , 2006, Biochemistry.
[50] C. Glass,et al. Sensors and signals: a coactivator/corepressor/epigenetic code for integrating signal-dependent programs of transcriptional response. , 2006, Genes & development.
[51] S. Dedieu,et al. Retinoids interfere with the AP1 signalling pathway in human breast cancer cells. , 2006, Cellular signalling.
[52] P. Brown,et al. Akt phosphorylates and suppresses the transactivation of retinoic acid receptor alpha. , 2006, The Biochemical journal.
[53] P. Lijnzaad,et al. Genome-wide location of the coactivator mediator: Binding without activation and transient Cdk8 interaction on DNA. , 2006, Molecular cell.
[54] W. Tansey,et al. The proteasome: a utility tool for transcription? , 2006, Current opinion in genetics & development.
[55] J. Bastien,et al. The phosphoinositide 3-kinase/Akt pathway is essential for the retinoic acid-induced differentiation of F9 cells , 2006, Oncogene.
[56] T. Takenawa,et al. Protein kinase A‐dependent increase in WAVE2 expression induced by the focal adhesion protein vinexin , 2006, Genes to cells : devoted to molecular & cellular mechanisms.
[57] I. Raška,et al. P38MAPK‐dependent phosphorylation and degradation of SRC‐3/AIB1 and RARα‐mediated transcription , 2006, The EMBO journal.
[58] R. Taneja,et al. Mouse embryocarcinoma F9 cells and retinoic acid: A model to study the molecular mechanisms of endodermal differentiation , 2006 .
[59] J. Samama,et al. Cyclin H binding to the RARalpha activation function (AF)-2 domain directs phosphorylation of the AF-1 domain by cyclin-dependent kinase 7. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[60] J. Workman,et al. The Proteasome Regulatory Particle Alters the SAGA Coactivator to Enhance Its Interactions with Transcriptional Activators , 2005, Cell.
[61] A. Means,et al. Peptidyl-Prolyl Isomerase 1 (Pin1) Serves as a Coactivator of Steroid Receptor by Regulating the Activity of Phosphorylated Steroid Receptor Coactivator 3 (SRC-3/AIB1) , 2005, Molecular and Cellular Biology.
[62] I. McEwan,et al. Structure and function of steroid receptor AF1 transactivation domains: induction of active conformations. , 2005, The Biochemical journal.
[63] Pawan Gupta,et al. Regulation of Co-repressive Activity of and HDAC Recruitment to RIP140 by Site-specific Phosphorylation * , 2005, Molecular & Cellular Proteomics.
[64] C. Rochette-Egly. Dynamic Combinatorial Networks in Nuclear Receptor-mediated Transcription* , 2005, Journal of Biological Chemistry.
[65] R. Bernards,et al. The Human Tumor Antigen PRAME Is a Dominant Repressor of Retinoic Acid Receptor Signaling , 2005, Cell.
[66] V. Vivat-Hannah,et al. Retinoids as therapeutic agents: today and tomorrow. , 2005, Mini reviews in medicinal chemistry.
[67] Pierre Chambon,et al. The nuclear receptor superfamily: a personal retrospect on the first two decades. , 2005, Molecular endocrinology.
[68] Ronald Kühne,et al. Recognition of proline-rich motifs by protein-protein-interaction domains. , 2005, Angewandte Chemie.
[69] Jing-kun Pan,et al. Activation of Rac1 by phosphatidylinositol 3‐kinase in vivo: role in activation of mitogen‐activated protein kinase (MAPK) pathways and retinoic acid‐induced neuronal differentiation of SH‐SY5Y cells , 2005, Journal of neurochemistry.
[70] S. Khan,et al. Mapping of phosphorylation sites of nuclear corepressor receptor interacting protein 140 by liquid chromatography‐tandem mass spectroscopy , 2005, Proteomics.
[71] B. O’Malley,et al. Transcriptional regulation by steroid receptor coactivator phosphorylation. , 2005, Endocrine reviews.
[72] K. Lu,et al. Phosphorylation-specific prolyl isomerization: is there an underlying theme? , 2005, Nature Cell Biology.
[73] D. Reinberg,et al. PARP-1 determines specificity in a retinoid signaling pathway via direct modulation of mediator. , 2005, Molecular cell.
[74] T. Klimkait,et al. The peptidyl–prolyl isomerase Pin1 regulates phospho-Ser77 retinoic acid receptor α stability , 2005 .
[75] H. Dyson,et al. Intrinsically unstructured proteins and their functions , 2005, Nature Reviews Molecular Cell Biology.
[76] S. Lalevée,et al. Vinexin β Interacts with the Non-phosphorylated AF-1 Domain of Retinoid Receptor γ (RARγ) and Represses RARγ-mediated Transcription* , 2005, Journal of Biological Chemistry.
[77] R. Price,et al. c-Jun N-Terminal Kinase Contributes to Aberrant Retinoid Signaling in Lung Cancer Cells by Phosphorylating and Inducing Proteasomal Degradation of Retinoic Acid Receptor α , 2005, Molecular and Cellular Biology.
[78] B. O’Malley,et al. Rush hour at the promoter: How the ubiquitin-proteasome pathway polices the traffic flow of nuclear receptor-dependent transcription , 2005, The Journal of Steroid Biochemistry and Molecular Biology.
[79] H. Gronemeyer,et al. Characterization of the Interaction between Retinoic Acid Receptor/Retinoid X Receptor (RAR/RXR) Heterodimers and Transcriptional Coactivators through Structural and Fluorescence Anisotropy Studies* , 2005, Journal of Biological Chemistry.
[80] S. Dedieu,et al. Transcriptional activities of retinoic acid receptors. , 2005, Vitamins and hormones.
[81] M. Karamouzis,et al. Retinoid receptor cross-talk in respiratory epithelium cancer chemoprevention. , 2005, Trends in molecular medicine.
[82] M. Privalsky,et al. SMRT and N-CoR Corepressors Are Regulated by Distinct Kinase Signaling Pathways* , 2004, Journal of Biological Chemistry.
[83] W. Miller,et al. Retinoic acid mediates degradation of IRS-1 by the ubiquitin–proteasome pathway, via a PKC-dependant mechanism , 2004, Oncogene.
[84] H. Gronemeyer,et al. Monitoring ligand-mediated nuclear receptor-coregulator interactions by noncovalent mass spectrometry. , 2004, European journal of biochemistry.
[85] B. Farboud,et al. Retinoic acid receptor-alpha is stabilized in a repressive state by its C-terminal, isotype-specific F domain. , 2004, Molecular endocrinology.
[86] J. Qin,et al. Selective phosphorylations of the SRC-3/AIB1 coactivator integrate genomic reponses to multiple cellular signaling pathways. , 2004, Molecular cell.
[87] J. Starrett,et al. Rational design of RAR‐selective ligands revealed by RARβ crystal stucture , 2004, EMBO reports.
[88] H. Hausen,et al. Ectopic Expression of Nonliganded Retinoic Acid Receptor β Abrogates AP-1 Activity by Selective Degradation of c-Jun in Cervical Carcinoma Cells* , 2004, Journal of Biological Chemistry.
[89] R. Aebersold,et al. A new, tenth subunit of TFIIH is responsible for the DNA repair syndrome trichothiodystrophy group A , 2004, Nature Genetics.
[90] Peter A. Jones,et al. Epigenetics in human disease and prospects for epigenetic therapy , 2004, Nature.
[91] Olivier Poch,et al. Signature of the oligomeric behaviour of nuclear receptors at the sequence and structural level , 2004, EMBO reports.
[92] J. Bastien,et al. Nuclear retinoid receptors and the transcription of retinoid-target genes. , 2004, Gene.
[93] Robert E. Cohen,et al. Proteasomes and their kin: proteases in the machine age , 2004, Nature Reviews Molecular Cell Biology.
[94] C. Glass,et al. A Corepressor/Coactivator Exchange Complex Required for Transcriptional Activation by Nuclear Receptors and Other Regulated Transcription Factors , 2004, Cell.
[95] E. Ezhkova,et al. Proteasomal ATPases link ubiquitylation of histone H2B to methylation of histone H3. , 2004, Molecular cell.
[96] M. Privalsky,et al. The role of corepressors in transcriptional regulation by nuclear hormone receptors. , 2004, Annual review of physiology.
[97] A. Feinberg,et al. The history of cancer epigenetics , 2004, Nature Reviews Cancer.
[98] C. Chiang,et al. Suppressive Effect of Receptor-interacting Protein 140 on Coregulator Binding to Retinoic Acid Receptor Complexes, Histone-modifying Enzyme Activity, and Gene Activation* , 2004, Journal of Biological Chemistry.
[99] J. Gustafsson,et al. Activation functions 1 and 2 of nuclear receptors: molecular strategies for transcriptional activation. , 2003, Molecular endocrinology.
[100] R. Deshaies,et al. Diverse roles for ubiquitin-dependent proteolysis in transcriptional activation , 2003, Nature Cell Biology.
[101] D. Moras,et al. Structure-activity relationship of nuclear receptor-ligand interactions. , 2003, Current topics in medicinal chemistry.
[102] M. Lambert,et al. Activation of nuclear receptors: a perspective from structural genomics. , 2003, Structure.
[103] S. Minucci,et al. Activation of Protein Kinase Cδ by All-trans-retinoic Acid* , 2003, Journal of Biological Chemistry.
[104] Adrian V. Lee,et al. SAFB2, a New Scaffold Attachment Factor Homolog and Estrogen Receptor Corepressor* , 2003, Journal of Biological Chemistry.
[105] B. Farboud,et al. Isotype-Restricted Corepressor Recruitment: a Constitutively Closed Helix 12 Conformation in Retinoic Acid Receptors β and γ Interferes with Corepressor Recruitment and Prevents Transcriptional Repression , 2003, Molecular and Cellular Biology.
[106] B. Farboud,et al. Retinoic Acid Receptors β and γ Do Not Repress, But Instead Activate Target Gene Transcription in Both the Absence and Presence of Hormone Ligand , 2003 .
[107] M. Muratani,et al. How the ubiquitin–proteasome system controls transcription , 2003, Nature Reviews Molecular Cell Biology.
[108] C. Chomienne,et al. Cyclin D3 Is a Cofactor of Retinoic Acid Receptors, Modulating Their Activity in the Presence of Cellular Retinoic Acid-binding Protein II* , 2003, The Journal of Biological Chemistry.
[109] L. Banaszak,et al. Effects of retinoid ligands on RIP140: molecular interaction with retinoid receptors and biological activity. , 2003, Biochemistry.
[110] Lucia Altucci,et al. Nuclear receptor superfamily: Principles of signaling , 2003 .
[111] Alfonso Bellacosa,et al. The phosphoinositide 3-kinase/AKT1 pathway involvement in drug and all-trans-retinoic acid resistance of leukemia cells. , 2003, Molecular cancer research : MCR.
[112] P. Tompa. Intrinsically unstructured proteins. , 2002, Trends in biochemical sciences.
[113] M. Hung,et al. Her2/neu induces all-transretinoic acid (ATRA) resistance in breast cancer cells , 2002, Oncogene.
[114] P. Chambon,et al. Phosphorylation by p38MAPK and recruitment of SUG‐1 are required for RA‐induced RARγ degradation and transactivation , 2002, The EMBO journal.
[115] P. Chambon,et al. Down-regulation of the Phosphatidylinositol 3-Kinase/Akt Pathway Is Involved in Retinoic Acid-induced Phosphorylation, Degradation, and Transcriptional Activity of Retinoic Acid Receptor γ2* , 2002, The Journal of Biological Chemistry.
[116] P. Lefebvre,et al. Retinoic Acid Receptors Inhibit AP1 Activation by Regulating Extracellular Signal-Regulated Kinase and CBP Recruitment to an AP1-Responsive Promoter , 2002, Molecular and Cellular Biology.
[117] N. McKenna,et al. Minireview: Nuclear Receptor Coactivators-An Update. , 2002, Endocrinology.
[118] A. Budhu,et al. Direct Channeling of Retinoic Acid between Cellular Retinoic Acid-Binding Protein II and Retinoic Acid Receptor Sensitizes Mammary Carcinoma Cells to Retinoic Acid-Induced Growth Arrest , 2002, Molecular and Cellular Biology.
[119] A. Sarasin,et al. XPD Mutations Prevent TFIIH-Dependent Transactivation by Nuclear Receptors and Phosphorylation of RARα , 2002, Cell.
[120] N. Colburn,et al. AP-1 transrepressing retinoic acid does not deplete coactivators or AP-1 monomers but may target specific Jun or Fos containing dimers , 2002, Oncogene.
[121] R. Kingston,et al. Cooperation between Complexes that Regulate Chromatin Structure and Transcription , 2002, Cell.
[122] S. Elgin,et al. Epigenetic Codes for Heterochromatin Formation and Silencing Rounding up the Usual Suspects , 2002, Cell.
[123] Marius Sudol,et al. WW and SH3 domains, two different scaffolds to recognize proline‐rich ligands , 2002, FEBS letters.
[124] T. Amachi,et al. Vinexin, CAP/ponsin, ArgBP2: a novel adaptor protein family regulating cytoskeletal organization and signal transduction. , 2002, Cell structure and function.
[125] Ralph A. Bradshaw,et al. Post‐Translational Modifications , 2002 .
[126] H. Gronemeyer,et al. Co-regulator recruitment and the mechanism of retinoic acid receptor synergy , 2002, Nature.
[127] N. McKenna,et al. 0013-7227/02/$15.00/0 Endocrinology 143(7):2461–2465 Printed in U.S.A. Copyright © 2002 by The Endocrine Society Minireview: Nuclear Receptor Coactivators—An Update , 2022 .
[128] Lucia Altucci,et al. Nuclear receptors in cell life and death , 2001, Trends in Endocrinology & Metabolism.
[129] G. Orphanides,et al. Estrogen receptors: orchestrators of pleiotropic cellular responses , 2001, EMBO reports.
[130] Á. Pascual,et al. Nuclear hormone receptors and gene expression. , 2001, Physiological reviews.
[131] C. Turck,et al. Growth Factors Signal to Steroid Receptors through Mitogen-activated Protein Kinase Regulation of p160 Coactivator Activity* , 2001, The Journal of Biological Chemistry.
[132] S. Khorasanizadeh,et al. Nuclear-receptor interactions on DNA-response elements. , 2001, Trends in biochemical sciences.
[133] A. Steinmetz,et al. Binding of ligands and activation of transcription by nuclear receptors. , 2001, Annual review of biophysics and biomolecular structure.
[134] F. Dilworth,et al. Nuclear receptors coordinate the activities of chromatin remodeling complexes and coactivators to facilitate initiation of transcription , 2001, Oncogene.
[135] T. Hunter,et al. Oncogenic kinase signalling , 2001, Nature.
[136] W. Tansey,et al. Transcriptional activation: risky business. , 2001, Genes & development.
[137] R. Goodman,et al. CREB-binding Protein and p300 in Transcriptional Regulation* , 2001, The Journal of Biological Chemistry.
[138] D. Moras,et al. Effects of ligand binding on the association properties and conformation in solution of retinoic acid receptors RXR and RAR. , 2001, Journal of molecular biology.
[139] Krzysztof Sliwa,et al. Functions of WW domains in the nucleus , 2001, FEBS letters.
[140] S. Minucci,et al. Activation of Rac1 and the p38 Mitogen-activated Protein Kinase Pathway in Response to All-trans-retinoic Acid* , 2001, The Journal of Biological Chemistry.
[141] F. Rastinejad. Retinoid X receptor and its partners in the nuclear receptor family. , 2001, Current opinion in structural biology.
[142] Xinli Hu,et al. Receptor-interacting Protein 140 Directly Recruits Histone Deacetylases for Gene Silencing* , 2000, The Journal of Biological Chemistry.
[143] D. Moras,et al. Structural studies on nuclear receptors , 2000, Cellular and Molecular Life Sciences CMLS.
[144] P. Chambon,et al. Dimerization with Retinoid X Receptors and Phosphorylation Modulate the Retinoic Acid-induced Degradation of Retinoic Acid Receptors α and γ through the Ubiquitin-Proteasome Pathway* , 2000, The Journal of Biological Chemistry.
[145] Y. Wan,et al. Identification of Retinoic Acid-Responsive Elements on the HNF1α and HNF4α Genes , 2000 .
[146] H. Gronemeyer,et al. Nuclear receptor ligand-binding domains: three-dimensional structures, molecular interactions and pharmacological implications. , 2000, Trends in pharmacological sciences.
[147] D. Moras,et al. Structural basis for isotype selectivity of the human retinoic acid nuclear receptor. , 2000, Journal of molecular biology.
[148] M. Petkovich,et al. Cytochrome P450RAI(CYP26) promoter: a distinct composite retinoic acid response element underlies the complex regulation of retinoic acid metabolism. , 2000, Molecular endocrinology.
[149] W. Lim,et al. Converging on proline: the mechanism of WW domain peptide recognition , 2000, Nature Structural Biology.
[150] P. Chambon,et al. TFIIH Interacts with the Retinoic Acid Receptor γ and Phosphorylates Its AF-1-activating Domain through cdk7* , 2000, The Journal of Biological Chemistry.
[151] F. Lin,et al. Unique anti-activator protein-1 activity of retinoic acid receptor beta. , 2000, Cancer research.
[152] S. Khorasanizadeh,et al. Structure of the RXR–RAR DNA‐binding complex on the retinoic acid response element DR1 , 2000, The EMBO journal.
[153] B. O’Malley,et al. Phosphorylation of Steroid Receptor Coactivator-1 , 2000, The Journal of Biological Chemistry.
[154] P. Chambon,et al. Crystal structure of a heterodimeric complex of RAR and RXR ligand-binding domains. , 2000, Molecular cell.
[155] M. Sudol,et al. The importance of being proline: the interaction of proline‐rich motifs in signaling proteins with their cognate domains , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[156] C. Glass,et al. The coregulator exchange in transcriptional functions of nuclear receptors. , 2000, Genes & development.
[157] T. Magee,et al. Identification of retinoic acid-responsive elements on the HNF1alpha and HNF4alpha genes. , 2000, Biochemical and biophysical research communications.
[158] P. Lefebvre,et al. Serine 157, a Retinoic Acid Receptor α Residue Phosphorylated by Protein Kinase C in Vitro, Is Involved in RXR·RARα Heterodimerization and Transcriptional Activity* , 1999, The Journal of Biological Chemistry.
[159] M. Koken,et al. Retinoic Acid Induces Proteasome-Dependent Degradation of Retinoic Acid Receptor α (RARα) and Oncogenic RARα Fusion Proteins , 1999 .
[160] C. Glass,et al. Molecular determinants of nuclear receptor-corepressor interaction. , 1999, Genes & development.
[161] M. Lazar,et al. The CoRNR motif controls the recruitment of corepressors by nuclear hormone receptors , 1999, Nature.
[162] P. Chambon,et al. Physical and Functional Interactions between Cellular Retinoic Acid Binding Protein II and the Retinoic Acid-Dependent Nuclear Complex , 1999, Molecular and Cellular Biology.
[163] D. Levinthal,et al. Distinct Roles for Cellular Retinoic Acid-binding Proteins I and II in Regulating Signaling by Retinoic Acid* , 1999, The Journal of Biological Chemistry.
[164] P Chambon,et al. Structural basis for engineering of retinoic acid receptor isotype-selective agonists and antagonists. , 1999, Chemistry & biology.
[165] M. Koken,et al. Retinoic acid induces proteasome-dependent degradation of retinoic acid receptor alpha (RARalpha) and oncogenic RARalpha fusion proteins. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[166] H. Gronemeyer,et al. The nuclear receptor ligand-binding domain: structure and function. , 1998, Current opinion in cell biology.
[167] P. Chambon,et al. Conformational adaptation of agonists to the human nuclear receptor RARγ , 1998, Nature Structural Biology.
[168] H. Gronemeyer,et al. Therapeutic potential of selective modulators of nuclear receptor action. , 1998, Current opinion in chemical biology.
[169] R. Ogawa. [Down regulation]. , 1998, Masui. The Japanese journal of anesthesiology.
[170] P. Chambon,et al. Stimulation of RARα Activation Function AF-1 through Binding to the General Transcription Factor TFIIH and Phosphorylation by CDK7 , 1997, Cell.
[171] David M. Heery,et al. A signature motif in transcriptional co-activators mediates binding to nuclear receptors , 1997, Nature.
[172] P. Chambon,et al. In vivo functional analysis of the Hoxa-1 3' retinoic acid response element (3'RARE). , 1997, Development.
[173] S. Nagpal,et al. Identification and Functional Separation of Retinoic Acid Receptor Neutral Antagonists and Inverse Agonists* , 1996, The Journal of Biological Chemistry.
[174] P. Chambon. A decade of molecular biology of retinoic acid receptors , 1996, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[175] Z. Dong,et al. Inhibition of tumor promoter-induced transformation by retinoids that transrepress AP-1 without transactivating retinoic acid response element. , 1996, Cancer research.
[176] P. Chambon,et al. Differential ligand‐dependent interactions between the AF‐2 activating domain of nuclear receptors and the putative transcriptional intermediary factors mSUG1 and TIF1. , 1996, The EMBO journal.
[177] William Bourguet,et al. A canonical structure for the ligand-binding domain of nuclear receptors , 1996, Nature Structural Biology.
[178] R. Evans,et al. The RXR heterodimers and orphan receptors , 1995, Cell.
[179] Jean-Paul Renaud,et al. Crystal structure of the RAR-γ ligand-binding domain bound to all-trans retinoic acid , 1995, Nature.
[180] P. Chambon,et al. Phosphorylation of the retinoic acid receptor-alpha by protein kinase A. , 1995, Molecular endocrinology.
[181] William Bourguet,et al. Crystal structure of the ligand-binding domain of the human nuclear receptor RXR-α , 1995, Nature.
[182] P. Chambon,et al. The N‐terminal part of TIF1, a putative mediator of the ligand‐dependent activation function (AF‐2) of nuclear receptors, is fused to B‐raf in the oncogenic protein T18. , 1995, The EMBO journal.
[183] P. Chambon,et al. RAR‐specific agonist/antagonists which dissociate transactivation and AP1 transrepression inhibit anchorage‐independent cell proliferation. , 1995, The EMBO journal.
[184] Hendrik G. Stunnenberg,et al. Retinoic Acid Receptors , 1995 .
[185] A. Fanjul,et al. A new class of retinoids with selective inhibition of AP-1 inhibits proliferation , 1994, Nature.
[186] P. Chambon,et al. The dimerization interfaces formed between the DNA binding domains of RXR, RAR and TR determine the binding specificity and polarity of the full‐length receptors to direct repeats. , 1994, The EMBO journal.
[187] P. Chambon,et al. Dimerization interfaces formed between the DNA binding domains determine the cooperative binding of RXR/RAR and RXR/TR heterodimers to DR5 and DR4 elements. , 1994, The EMBO journal.
[188] Z. Dong,et al. Blocking of tumor promoter-induced AP-1 activity inhibits induced transformation in JB6 mouse epidermal cells. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[189] P. Chambon,et al. RARs and RXRs: evidence for two autonomous transactivation functions (AF‐1 and AF‐2) and heterodimerization in vivo. , 1993, The EMBO journal.
[190] S. Kliewer,et al. Structure of the retinoid X receptor alpha DNA binding domain: a helix required for homodimeric DNA binding. , 1993, Science.
[191] P. Brickell,et al. The nuclear retinoid receptors. , 1993, International journal of experimental pathology.
[192] P. Chambon,et al. All-trans and 9-cis retinoic acid induction of CRABPII transcription is mediated by RAR-RXR heterodimers bound to DR1 and DR2 repeated motifs , 1992, Cell.
[193] P. Chambon,et al. Multiplicity generates diversity in the retinoic acid signalling pathways. , 1992, Trends in biochemical sciences.
[194] P. Chambon,et al. Promoter context- and response element-dependent specificity of the transcriptional activation and modulating functions of retinoic acid receptors , 1992, Cell.
[195] K. Umesono,et al. A direct repeat in the cellular retinol-binding protein type II gene confers differential regulation by RXR and RAR , 1991, Cell.
[196] P. Chambon,et al. A retinoic acid response element is present in the mouse cellular retinol binding protein I (mCRBPI) promoter. , 1991, The EMBO journal.
[197] P. Chambon,et al. Negative regulation of the rat stromelysin gene promoter by retinoic acid is mediated by an AP1 binding site. , 1990, The EMBO journal.
[198] M. Sporn,et al. Interleukin-1 stimulates and all-trans-retinoic acid inhibits collagenase gene expression through its 5' activator protein-1-binding site. , 1990, Molecular endocrinology.
[199] H. Stunnenberg,et al. Identification of a retinoic acid responsive element in the retinoic acid receptor & beta;gene , 1990, Nature.
[200] B. Sefton,et al. Protein kinases. , 1989, Cancer cells.
[201] L. Beevers. Post-Translational Modifications , 1982 .